These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of alternative transcripts of NSD1 gene in Sotos Syndrome patients and healthy subjects. Conteduca G, Testa B, Baldo C, Arado A, Malacarne M, Candiano G, Garbarino A, Coviello DA, Cantoni C. Gene; 2023 Jan 30; 851():146970. PubMed ID: 36261088 [Abstract] [Full Text] [Related]
6. Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. Kudithipudi S, Lungu C, Rathert P, Happel N, Jeltsch A. Chem Biol; 2014 Feb 20; 21(2):226-37. PubMed ID: 24412544 [Abstract] [Full Text] [Related]
7. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation. Qiao Q, Li Y, Chen Z, Wang M, Reinberg D, Xu RM. J Biol Chem; 2011 Mar 11; 286(10):8361-8368. PubMed ID: 21196496 [Abstract] [Full Text] [Related]
8. Dynamic behavior of the post-SET loop region of NSD1: Implications for histone binding and drug development. Graham SE, Tweedy SE, Carlson HA. Protein Sci; 2016 May 11; 25(5):1021-9. PubMed ID: 26940890 [Abstract] [Full Text] [Related]
9. NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas. Su X, Zhang J, Mouawad R, Compérat E, Rouprêt M, Allanic F, Parra J, Bitker MO, Thompson EJ, Gowrishankar B, Houldsworth J, Weinstein JN, Tost J, Broom BM, Khayat D, Spano JP, Tannir NM, Malouf GG. Cancer Res; 2017 Sep 15; 77(18):4835-4845. PubMed ID: 28754676 [Abstract] [Full Text] [Related]
10. Histone H3 lysine 36 methylation antagonizes silencing in Saccharomyces cerevisiae independently of the Rpd3S histone deacetylase complex. Tompa R, Madhani HD. Genetics; 2007 Feb 15; 175(2):585-93. PubMed ID: 17179083 [Abstract] [Full Text] [Related]
11. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Berdasco M, Ropero S, Setien F, Fraga MF, Lapunzina P, Losson R, Alaminos M, Cheung NK, Rahman N, Esteller M. Proc Natl Acad Sci U S A; 2009 Dec 22; 106(51):21830-5. PubMed ID: 20018718 [Abstract] [Full Text] [Related]
12. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer. Xiong Q, Zhou Y, Zhang S, Zhang Y, Xu Y, Yang Y, Zhou C, Zeng Z, Han J, Zhu Q. Cancer Med; 2023 May 22; 12(9):10961-10978. PubMed ID: 37062069 [Abstract] [Full Text] [Related]